Brookings Roundtable on Active Medical Product Surveillance: Overview of FDA’s Sentinel Initiative

Project Title	Brookings Roundtable on Active Medical Product Surveillance: Overview of FDA’s Sentinel Initiative
Date	Tuesday, September 6, 2011
Description	On September 7, the Engelberg Center hosted the first of the three-part Sentinel Initiative 101 Webinar Series, “Overview of FDA’s Sentinel Initiative” to review ongoing activities and accomplishments. The roundtable featured a presentation from Dr. Judy Racoosin, Sentinel Initiative Scientific Lead, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Dr. Racoosin’s presentation provided a high-level review of the Sentinel Initiative’s scope and achievements including: FDA’s 3-year vision for the Sentinel Initiative A brief overview of the role of the Mini-Sentinel pilot, the Observational Medical Outcomes Partnership, the Federal Partners Collaboration, and the Brookings Institution cooperative agreement Next steps for the Sentinel Initiative
Host	Mark McClellan MD, PhD, MPA; Engelberg Center for Health Care Reform, Brookings Institution, Washington, DC
Location	https://www.brookings.edu/events/brookings-roundtable-on-active-medical-product-surveillance-overview-of-fdas-sentinel-initiative/
Presenters	Judy Racoosin MD, MPH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Springs, MD
Related Assessments	https://www.brookings.edu/events/brookings-active-surveillance-implementation-co…
Event Type	Workshop

Search form